NCT06435195 Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases
| NCT ID | NCT06435195 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | Pituitary Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2024-01-01 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to systematically describe the clinical characteristics and outcomes of patients with pituitary complex and rare diseases at Peking Union Medical College Hospital. The main questions it aims to answer are: * What are the influencing factors and rates of remission? * What are the comorbidities associated with these diseases? * What are the perioperative events, radiological findings, and pathological features? Researchers will compare different patient groups to see if there are significant differences in these outcomes. Participants will: * Undergo detailed clinical evaluations. * Provide medical history and data for analysis. * Participate in follow-up assessments to monitor disease progression and treatment outcomes.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with rare sellar diseases including but not limited to pituitary adenomas (such as Thyrotropin-secreting pituitary adenomas, GH-secreting adenomas), craniopharyngiomas, Rathke's cleft cysts, sellar region germ cell tumors, cavernous sinus syndrome, and other diseases * Detailed medical history, including clinical symptoms, treatment plans and follow-up outcomes Exclusion Criteria: * Incomplete medical records, especially missing key imaging diagnostic results * Patients with coexisting primary central nervous system diseases unrelated to sellar region diseases (such as severe traumatic brain injury) * Patients whose sellar region pathological diagnosis was changed or overturned during the follow-up period
Contact & Investigator
Yong Yao, MD
PRINCIPAL INVESTIGATOR
Department of Neurosurgery, Peking Union Medical College Hospital
Frequently Asked Questions
Who can join the NCT06435195 clinical trial?
This trial is open to participants of all sexes, studying Pituitary Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06435195 currently recruiting?
Yes, NCT06435195 is actively recruiting participants. Contact the research team at yaoyong@pumch.cn for enrollment information.
Where is the NCT06435195 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06435195 clinical trial?
NCT06435195 is sponsored by Peking Union Medical College Hospital. The principal investigator is Yong Yao, MD at Department of Neurosurgery, Peking Union Medical College Hospital. The trial plans to enroll 3,000 participants.